Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Rapport Therapeutics, Inc. (RAPP) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$20.00M |
|
$-19.86M |
|
-- |
|
$20.00M |
|
$44.22M |
|
$-24.21M |
|
$4.36M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-19.86M |
|
$-24.21M |
|
$-24.35M |
|
47.24M |
|
47.24M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$484.69M |
|
$2.52M |
|
$12.90M |
|
$497.60M |
|
$17.90M |
|
-- |
|
$8.19M |
|
$26.09M |
|
$471.51M |
|
$471.51M |
|
$471.51M |
|
47.81M |
|
| Cash Flow Statement Financials | |
$-13.06M |
|
$37.94M |
|
$0.53M |
|
$52.75M |
|
$78.16M |
|
$25.41M |
|
$6.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.08 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-121.08% |
|
-121.08% |
|
-- |
|
-99.28% |
|
-99.28% |
|
$-13.15M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
344.83 |
|
0.26 |
|
-4.21% |
|
-4.21% |
|
-3.99% |
|
-4.21% |
|
$9.86 |
|
$-0.28 |
|
$-0.28 |
|